Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
estriol (1 trial)
sodium chloride (1 trial)
tranexamic acid (cyklokapron) (1 trial)
Epistaxis (Phase 2)
Telangiectasia, Hereditary Hemorrhagic (Phase 2)
Telangiectasis (Phase 2)
Trials (1 total)
Trial APIs (4 total)